Unknown

Dataset Information

0

Studies of stereocontrolled allylation reactions for the total synthesis of phorboxazole A.


ABSTRACT: A highly convergent total synthesis of the potent anticancer agent (+)-phorboxazole A (1) is accomplished. Four components (3-6) are assembled with considerations for control of absolute and relative stereochemistry. Iterative asymmetric allylation methodology addresses key stereochemical features in the preparation of the 2,6-cis- and 2,6-trans-tetrahydropyranyl rings of the C3-C19 component (3). The stereocontrolled asymmetric allylation process is also used for development of the C28-C41 fragment (4). Novel Barbier coupling reactions of alpha-iodomethyl oxazoles and related thiazoles are described with samarium iodide. The convergent assembly of components 4 and 5 features formation of the fully substituted C22-C26 pyran by intramolecular capture of an allyl cation intermediate with high facial selectivity, and further efforts lead to E-C19/C20 olefination. The synthesis culminates with use of a modified Julia olefination for attachment of the C42-C46 segment and subsequent late-stage macrocyclization by installation of the (Z)-C2/C3 alpha,beta-unsaturated lactone.

SUBMITTER: Williams DR 

PROVIDER: S-EPMC514434 | biostudies-other | 2004 Aug

REPOSITORIES: biostudies-other

altmetric image

Publications

Studies of stereocontrolled allylation reactions for the total synthesis of phorboxazole A.

Williams David R DR   Kiryanov Andre A AA   Emde Ulrich U   Clark Michael P MP   Berliner Martin A MA   Reeves Jonathan T JT  

Proceedings of the National Academy of Sciences of the United States of America 20040726 33


A highly convergent total synthesis of the potent anticancer agent (+)-phorboxazole A (1) is accomplished. Four components (3-6) are assembled with considerations for control of absolute and relative stereochemistry. Iterative asymmetric allylation methodology addresses key stereochemical features in the preparation of the 2,6-cis- and 2,6-trans-tetrahydropyranyl rings of the C3-C19 component (3). The stereocontrolled asymmetric allylation process is also used for development of the C28-C41 frag  ...[more]

Similar Datasets

| S-EPMC5262430 | biostudies-literature
| S-EPMC4834877 | biostudies-literature
| S-EPMC6593186 | biostudies-literature
| S-EPMC2701212 | biostudies-literature
| S-EPMC5716625 | biostudies-literature
| S-EPMC9056333 | biostudies-literature
| S-EPMC3763838 | biostudies-literature
| S-EPMC4795151 | biostudies-literature
| S-EPMC2712115 | biostudies-literature
| S-EPMC3513937 | biostudies-literature